Literature DB >> 24179644

Combined modalities treatment of pulmonary metastasis from an urachal adenocarcinoma.

Fabrice Piégay, Jean-François Mornex.   

Abstract

Urachal adenocarcinoma is a rare neoplasm of the bladder. Most of these tumors arise from urachal remnants in the dome of the bladder and extend into the umbilicus. These tumors can recur and most commonly metastasize to lymph nodes, retroperitoneum, lungs, liver and bone. Here we report a case of an urachal adenocarcinoma followed for seven years with lung metastasis for three years.

Entities:  

Keywords:  bladder; lung; urachus

Year:  2013        PMID: 24179644      PMCID: PMC3804807          DOI: 10.4081/rt.2013.e32

Source DB:  PubMed          Journal:  Rare Tumors        ISSN: 2036-3605


  16 in total

Review 1.  Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer.

Authors:  A D Thornton; P Ravn; M Winslet; K Chester
Journal:  Br J Surg       Date:  2006-12       Impact factor: 6.939

2.  Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma.

Authors:  L Spencer Krane; A Karim Kader; Edward A Levine
Journal:  J Surg Oncol       Date:  2011-08-30       Impact factor: 3.454

3.  Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.

Authors:  Richard A Ashley; Brant A Inman; Thomas J Sebo; Bradley C Leibovich; Michael L Blute; Eugene D Kwon; Horst Zincke
Journal:  Cancer       Date:  2006-08-15       Impact factor: 6.860

4.  Population based survival data on urachal tumors.

Authors:  Jehonathan H Pinthus; Riad Haddad; John Trachtenberg; Eric Holowaty; Jeff Bowler; Andrew M Herzenberg; Michael Jewett; Neil E Fleshner
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

5.  Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement.

Authors:  Joseph P Erinjeri; Abigail J Fong; Nancy E Kemeny; Karen T Brown; George I Getrajdman; Stephen B Solomon
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

6.  The clinical epidemiology of urachal carcinoma: results of a large, population based study.

Authors:  H Max Bruins; Otto Visser; Martine Ploeg; Christina A Hulsbergen-van de Kaa; Lambertus A L M Kiemeney; J Alfred Witjes
Journal:  J Urol       Date:  2012-08-15       Impact factor: 7.450

7.  Preliminary report of multimodal treatment with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus.

Authors:  Manabu Tatokoro; Satoru Kawakami; Junji Yonese; Yasuhisa Fujii; Yuhei Okubo; Shinya Yamamoto; Hideki Takeshita; Yoshinobu Komai; Yuichi Ishikawa; Iwao Fukui
Journal:  Int J Urol       Date:  2008-09       Impact factor: 3.369

8.  Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.

Authors:  Anuradha Gopalan; David S Sharp; Samson W Fine; Satish K Tickoo; Harry W Herr; Victor E Reuter; Semra Olgac
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

9.  Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.

Authors:  Julian R Molina; J Fernando Quevedo; Alfred F Furth; Ronald L Richardson; Horst Zincke; Patrick A Burch
Journal:  Cancer       Date:  2007-12-01       Impact factor: 6.860

10.  Brain metastasis from urachal carcinoma: the importance of locally aggressive treatment.

Authors:  Daniel Taussky; Pierre I Karakiewicz; Mathieu Latour; Normand Blais
Journal:  Rare Tumors       Date:  2012-03-20
View more
  1 in total

1.  Unusual presentation of urachal adenocarcinoma with genitourinary cutaneous metastasis.

Authors:  Yin-Hui Yang; Yan Zhu; Xiang-Wei Zhu; Hong-Juan Tang; Jian-Guo Hou; Wan-Hai Xu
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.